Your browser doesn't support javascript.
loading
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial.
Liu, Jihong; Yin, Rutie; Wu, Lingying; Zhu, Jianqing; Lou, Ge; Wu, Xiaohua; Zhou, Qi; Gao, Yunong; Kong, Beihua; Lu, Xin; Wang, Jing; Chen, Youguo; Cheng, Ying; Wang, Yueling; Lu, Weiguo; Li, Wei; Ma, Xin; Hsu, Kate.
Afiliação
  • Liu J; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yin R; Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wu L; Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Zhu J; Key Laboratory of Obstetrics & Gynecologic and Pediatric Diseases and Birth Defects of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Lou G; Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Wu X; Department of Gynecologic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
  • Zhou Q; Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
  • Gao Y; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Kong B; Chongqing Cancer Hospital, Chongqing, China.
  • Lu X; Beijing Cancer Hospital, Beijing, China.
  • Wang J; Qilu Hospital of Shandong University, Jinan, China.
  • Chen Y; Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Cheng Y; Hunan Cancer Hospital, Changsha, China.
  • Wang Y; The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Lu W; Jilin Cancer Hospital, Changchun, China.
  • Li W; No. 1 Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
  • Ma X; Women's Hospital School of Medicine, Zhejiang University, Hangzhou, China.
  • Hsu K; Oncology Center, The First Hospital of Jilin University, Changchun, China.
Asia Pac J Clin Oncol ; 18(6): 714-722, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35357078
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Female / Humans Idioma: En Revista: Asia Pac J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Female / Humans Idioma: En Revista: Asia Pac J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China